Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus

PLoS Neglected Tropical Diseases

Volumn 5, Issue 6, 2011, Pages

  MacNeil, Adam ^a   Reed, Zachary ^a   Rollin, Pierre E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONGO; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC VALUE; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FILOVIRIDAE; HUMAN; NONHUMAN; PHILIPPINES; PROCESS DEVELOPMENT; RESTON EBOLAVIRUS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPECIES DIFFERENCE; UGANDA; VIRUS IDENTIFICATION; BLOOD; DEMOCRATIC REPUBLIC CONGO; IMMUNOLOGY; METHODOLOGY; TIME;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; DEMOCRATIC REPUBLIC OF THE CONGO; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHILIPPINES; TIME FACTORS; UGANDA;

EID: 79959850960     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001175     Document Type: Article

References (43)

1. Kuhn JH, Becker S, Ebihara H, Geisbert TW, Johnson KM, et al. (2010) Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 155: 2083-2103.
2. WHO (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56: 271-293.
3. WHO (1978) Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 56: 247-270.
4. (2001) Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep 50: 73-77.
5. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, et al. (1999) The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 (Suppl 1): S76-86.
6. Formenty P, Hatz C, Le Guenno B, Stoll A, Rogenmoser P, et al. (1999) Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 179 (Suppl 1): S48-53.
7. Georges AJ, Leroy EM, Renaut AA, Benissan CT, Nabias RJ, et al. (1999) Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis 179 (Suppl 1): S65-75.
8. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, et al. (2010) Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis 16: 1087-1092.
9. Macneil A, Farnon EC, Wamala J, Okware S, Cannon DL, et al. (2010) Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda. Emerg Infect Dis 16: 1969-1972.
10. (1989) Ebola Virus Infection in Imported Primates - Virginia, 1989. MMWR Morb Mortal Wkly Rep 38: 831-832, 837-838.
11. Hayes CG, Burans JP, Ksiazek TG, Del Rosario RA, Miranda ME, et al. (1992) Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. Am J Trop Med Hyg 46: 664-671.
12. Miranda ME, Yoshikawa Y, Manalo DL, Calaor AB, Miranda NL, et al. (2002) Chronological and spatial analysis of the 1996 Ebola Reston virus outbreak in a monkey breeding facility in the Philippines. Exp Anim 51: 173-179.
13. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, et al. (2009) Discovery of swine as a host for the Reston ebolavirus. Science 325: 204-206.
14. (1990) Update: Filovirus Infections Among Persons with Occupational Exposure to Nonhuman Primates. MMWR Morb Mortal Wkly Rep 39: 266, 273.
15. Miranda ME, White ME, Dayrit MM, Hayes CG, Ksiazek TG, et al. (1991) Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet 337: 425-426.
16. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. (2008) Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4: e1000212.
17. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, et al. (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179 (Suppl 1): S177-187.
18. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, et al. (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5: 423-426.
19. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, et al. (2004) Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78: 4330-4341.
20. Onyango CO, Opoka ML, Ksiazek TG, Formenty P, Ahmed A, et al. (2007) Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 196 (Suppl 2): S193-198.
21. Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, et al. (1999) Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 (Suppl 1): S28-35.
22. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al. (2000) Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355: 2210-2215.
23. Groseth A, Feldmann H, Strong JE, (2007) The ecology of Ebola virus. Trends Microbiol 15: 408-416.
24. Feldmann H, Geisbert TW,.Ebola haemorrhagic fever. Lancet.
25. Richman DD, Cleveland PH, McCormick JB, Johnson KM, (1983) Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes. J Infect Dis 147: 268-271.
26. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, et al. (1995) Isolation and partial characterisation of a new strain of Ebola virus. Lancet 345: 1271-1274.
27. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ, (1999) ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 179 (Suppl 1): S192-198.
28. Elliott LH, Bauer SP, Perez-Oronoz G, Lloyd ES, (1993) Improved specificity of testing methods for filovirus antibodies. J Virol Methods 43: 85-89.
29. Brandt WE, Buescher EL, Hetrick FM, (1967) Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg 16: 339-347.
30. Prehaud C, Hellebrand E, Coudrier D, Volchkov VE, Volchkova VA, et al. (1998) Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol 79 (Pt 11): 2565-2572.
31. Saijo M, Niikura M, Morikawa S, Ksiazek TG, Meyer RF, et al. (2001) Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol 39: 1-7.
32. Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, et al. (2010) Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol 17: 1723-1728.
33. Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, et al. (2010) Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog 6: e1000904.
34. Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, et al. (1999) Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 179 (Suppl 1): S102-107.
35. Gonzalez JP, Nakoune E, Slenczka W, Vidal P, Morvan JM, (2000) Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic. Microbes Infect 2: 39-44.
36. Becquart P, Wauquier N, Mahlakoiv T, Nkoghe D, Padilla C, et al. (2010) High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 5: e9126.
37. Wauquier N, Becquart P, Gasquet C, Leroy EM, (2009) Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis 15: 1136-1137.
38. Wilson JA, Hevey M, Bakken R, Guest S, Bray M, et al. (2000) Epitopes involved in antibody-mediated protection from Ebola virus. Science 287: 1664-1666.
39. Maruyama T, Rodriguez LL, Jahrling PB, Sanchez A, Khan AS, et al. (1999) Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol 73: 6024-6030.
40. Takada A, Ebihara H, Jones S, Feldmann H, Kawaoka Y, (2007) Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 25: 993-999.
41. Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y, (2007) Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 196 (Suppl 2): S347-356.
42. Shedlock DJ, Bailey MA, Popernack PM, Cunningham JM, Burton DR, et al. Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology 401: 228-235.
43. Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, et al. (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11: 786-790.